MedTrace Logo

Treatment of Spastic Equinovarus Foot After Stroke

NCT00199589 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2008-12-30

No results posted yet for this study

Summary

This study evaluates treatment for spastic foot after stroke using ankle foot orthosis with or without selective injection of BTA (Botox).

Conditions

  • Spastic Equinovarus

Interventions

DRUG

Botulinic toxin (Botox)

Patients may benefit, depending on the draw, in addition to their orthosis, intramuscular injections of botulinum toxin.These injections are among 6 in the muscles posterior (rear) of the leg paralyzed with tracking electromyographic to ensure the accuracy of the injection.

Sponsors & Collaborators

  • Allergan

    collaborator INDUSTRY

  • University Hospital, Limoges

    lead OTHER

Principal Investigators

  • Jean-Yves Salle, MD · University Hospital, Limoges

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2002-10-31
Completion
2007-12-31

Countries

  • France

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00199589 on ClinicalTrials.gov